Utama › Penyakit Sel Sabit › Texas
Kajian klinikal Penyakit Sel Sabit di Texas
11 kajian untuk Penyakit Sel Sabit sedang mencari peserta di lokasi di Texas.
Bandar di Texas
Teks kajian rasmi (Bahasa Inggeris)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Texas Childrens Cancer and Hematology Center, Houston
- U of TX Health Science Ct, Houston
Mengambil pesertaFasa 3
Umur 12 hingga 100 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06439082A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Texas Children's Hospital_Houston, Houston
- UT Health University of Texas, Houston
Mengambil pesertaFasa 3
Umur 2 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT06609226A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- UT Health University of Texas, Houston
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06612268A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- UT Health Science Center, Houston
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Umur 12 hingga 55 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06546670ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Children's Blood and Cancer Center of Central Texas, Austin
- North Texas Hemophilia and Thrombosis Program - Pediatric Program / Center for Cancer & Blood Disorders, Dallas
- North Texas Comprehensive Hemophilia Treatment Center, Dallas
- dan 3 lagi
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT04398628The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Baylor College of Medicine- Site Number : 8400055, Houston
Mengambil pesertaFasa 3
Umur 10 hingga 65 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT06975865Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Texas Children's Hopsital (NT-DMT), Houston
- Texas Children's Hospital (MRD-HCT), Houston
- UT San Antonio (NT-DMT), San Antonio
Mengambil pesertaKajian pemerhatian
Umur 3 hingga 20 · Semua jantina · Dikemas kini 4 Jun 2026 · NCT06941389Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
- Site # 8400004, Houston
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 15 Apr 2026 · NCT07247188Sickle Cell Kidney Biorepository
- Parkland Memorial Hospital, Dallas
- University of Texas Southwestern Medical Center, Dallas
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 65 · Semua jantina · Dikemas kini 13 Apr 2026 · NCT07064174Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
- Baylor College of Medicine, Houston
Mengambil pesertaFasa 2
Umur 15 hingga 40 · Semua jantina · Dikemas kini 13 Mac 2026 · NCT06260891Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- University of Texas at Houston, Houston
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jun 2025 · NCT06385886Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.